EMBECTA CORP. Finance Lease, Right-of-Use Asset, Amortization
EMBECTA CORP. (EMBC) reported Finance Lease, Right-of-Use Asset, Amortization of $1.80 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-07
- EMBECTA CORP. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $1.20M, a 0.00% change year-over-year.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $600.00K.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $700.00K.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for the quarter ending 2025-03-31 was $1.20M.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for fiscal 2025 was $2.50M, a 0.00% change from fiscal 2024.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for fiscal 2024 was $2.50M, a 4.17% increase from fiscal 2023.
- EMBECTA CORP. finance lease, right-of-use asset, amortization for fiscal 2023 was $2.40M.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.80M 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-05 | $1.80M derived: sum of 2 quarters · filed 2026-05-05 | $2.50M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2025-12-31 | $600.00K 10-Q · filed 2026-02-05 | $1.30M derived: sum of 2 quarters · filed 2026-02-05 | ||
| 2025-09-30 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $2.50M 10-K · filed 2025-11-25 | ||
| 2025-06-30 | $1.80M 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $1.20M 10-Q · filed 2026-05-05 | |||
| 2024-09-30 | $2.50M 10-K · filed 2025-11-25 | |||
| 2023-12-31 | $600.00K 10-Q · filed 2026-02-05 | |||
| 2023-09-30 | $2.40M 10-K · filed 2025-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |